Table 6. Association between psychosocial stress and composite neuroendocrine biomarker index among monoracial non-Hispanic Black women overall and by HIV serostatus (n = 48).

	Unadjusted model		Full model a		Parsimonious Model b
	β (95% CI)	p	β (95% CI)	p	β (95% CI)	p
Overall (n = 48)
Psychosocial stress latent profile membership
Low	ref		ref		ref
Moderate	0.53 (-0.06, 1.13)	0.078	0.30 (-0.42, 1.03)	0.40	0.33 (-0.24, 0.90)	0.25
High	0.73 (-0.11, 1.57)	0.088	1.32 (0.20, 2.43)	0.022	1.31 (0.41, 2.21)	0.0053
Among WLWH (n = 31)
Psychosocial stress latent profile membership
Low	ref		ref		ref
Moderate	0.37 (-0.35, 1.09)	0.30	0.13 (-1.41, 1.68)	0.86	0.06 (-0.76, 0.88)	0.88
High	0.98 (0.01, 1.96)	0.049	1.93 (0.02, 3.83)	0.048	1.64 (0.54, 2.73)	0.0052
Among HIV-negative women (n = 17)
Psychosocial stress latent profile membership
Low	ref		ref		ref
Moderate	0.72 (-0.37, 1.81)	0.18	0.36 (-0.66, 1.38)	0.38	0.32 (-0.41, 1.06)	0.32
High	0.17 (-1.52, 1.86)	0.84	2.54 (0.41, 4.67)	0.030	2.51 (0.93, 4.08)	0.0080

Abbreviations: CI, confidence interval; WLWH, women living with HIV; ref, reference group.

Bolded numeric values indicate p<0.05.

^a Adjusted for HIV status (only in the overall sample), age, education at study entry, income, current smoking, alcohol use, recent substance use, use of a prescribed psychotropic medication, body mass index, menopausal status, CD4+ T cell count (only among WLWH), and HIV viral load (only among WLWH).

^b In the overall sample, adjusted for HIV status, age, income, alcohol use, recent substance use, and body mass index. Among WLWH, adjusted for age, recent substance use, use of a prescribed psychotropic medication, and HIV viral load. Among HIV-negative women, adjusted for age, education at study entry, current smoking, alcohol use, recent substance use, body mass index, and menopausal status.